Overview
Description
About
9900 Bren Road East
Eden Prairie, 55344, MN
United States
Latest press releases
NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE: TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE: UNH) acquired Amedisys in a deal completed today.
Following is a summary of the changes that will take place prior to the open of trading on the effective date:
Effective Date | Index Name | Action | Company Name | Ticker | GICS Sector | |
August 19, 2025 | S&P MidCap 400 | Addition | Twilio | TWLO | Information Technology | |
August 19, 2025 | S&P MidCap 400 | Deletion | Amedisys | AMED | Health Care | |
For more information about S&P Dow Jones Indices, please visit www.spdji.com
ABOUT S&P DOW JONES INDICES
S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.
S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.
FOR MORE INFORMATION:
S&P Dow Jones Indices
index_services@spglobal.com
Media Inquiries
spdji.comms@spglobal.com
View original content:https://www.prnewswire.com/news-releases/twilio-set-to-join-sp-midcap-400-302530650.html
SOURCE S&P Dow Jones Indices
SAN FRANCISCO, June 26, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises UnitedHealth Group investors that the firm is investigating potential legal claims following revelations that the company is under criminal investigation for fraud and allegedly made false statements to investors. Current shareholders are encouraged to contact the firm.
On May 13, 2025, UnitedHealth suspended its 2025 fiscal guidance and announced that its CEO Andrew Witty had resigned for "personal reasons." Two days later, on May 15, 2025, The Wall Street Journal reported that UnitedHealth is under criminal investigation by the healthcare fraud unit of the U.S. Department of Justice (DOJ) for conduct in its Medicare Advantage program. The company is also facing a civil DOJ investigation into its Medicare billing practices, and a separate antitrust investigation concerning its Optum health services division. An investor class action is also pending against UnitedHealth in the U.S. District Court for the District of Minnesota. UnitedHealth's stock price has plummeted by approximately half since April 2025 following these disclosures, inflicting massive losses on shareholders.
We are investigating potential wrongdoing by UnitedHealth's officers and directors in connection with these facts and allegations.
If you own stock in UnitedHealth, you may have legal options. To learn more, please contact us today at https://www.classactionlawyers.com/unitedhealthinvestoralert.
About Schubert Jonckheer & Kolbe LLP
Schubert Jonckheer & Kolbe represents shareholders, employees, and consumers in class actions against corporate defendants, as well as shareholders in derivative actions against officers and directors. The firm is based in San Francisco, and with the help of co-counsel, litigates cases nationwide.
Contact
Schubert Jonckheer & Kolbe LLP
Tel: (415) 788-4220
SOURCE Schubert Jonckheer & Kolbe LLP